NASDAQ: UPB
Upstream Bio Inc Stock

$9.61+0.55 (+6.07%)
Updated Mar 14, 2025
UPB Price
$9.61
Fair Value Price
N/A
Market Cap
$515.49M
52 Week Low
$6.65
52 Week High
$29.46
P/E
-1.72x
P/B
1.1x
P/S
94.91x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.37M
Earnings
-$62.81M
Gross Margin
100%
Operating Margin
-2,650.04%
Profit Margin
-3,223.4%
Debt to Equity
0.03
Operating Cash Flow
-$59M
Beta
2.4
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

UPB Overview

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine UPB's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
UPB
Ranked
#151 of 484

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important UPB news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how UPB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

UPB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UPB is good value based on its book value relative to its share price (1.1x), compared to the US Biotechnology industry average (4.68x)
P/B vs Industry Valuation
UPB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more UPB due diligence checks available for Premium users.

Valuation

UPB price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-1.72x
Industry
-118.09x
Market
3,446.61x

UPB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.1x
Industry
4.68x
UPB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

UPB's financial health

Profit margin

Revenue
$613.0k
Net Income
-$21.2M
Profit Margin
-3,554.6%
UPB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
UPB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$481.7M
Liabilities
$11.9M
Debt to equity
0.03
UPB's short-term assets ($479.16M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UPB's short-term assets ($479.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UPB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$19.6M
Investing
$41.9M
Financing
$270.6M
UPB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

UPB vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
UPBC$515.49M+6.07%-1.72x1.10x
CGEMF$514.33M-1.46%-3.16x0.87x
ANABC$513.06M-0.65%-3.27x7.24x
TRVID$518.84M+7.31%-15.34x8.80x
URGND$510.26M+1.56%-3.74x-57.96x

Upstream Bio Stock FAQ

What is Upstream Bio's quote symbol?

(NASDAQ: UPB) Upstream Bio trades on the NASDAQ under the ticker symbol UPB. Upstream Bio stock quotes can also be displayed as NASDAQ: UPB.

If you're new to stock investing, here's how to buy Upstream Bio stock.

What is the 52 week high and low for Upstream Bio (NASDAQ: UPB)?

(NASDAQ: UPB) Upstream Bio's 52-week high was $29.46, and its 52-week low was $6.65. It is currently -67.38% from its 52-week high and 44.51% from its 52-week low.

How much is Upstream Bio's stock price per share?

(NASDAQ: UPB) Upstream Bio stock price per share is $9.61 today (as of Mar 14, 2025).

What is Upstream Bio's Market Cap?

(NASDAQ: UPB) Upstream Bio's market cap is $515.49M, as of Mar 16, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Upstream Bio's market cap is calculated by multiplying UPB's current stock price of $9.61 by UPB's total outstanding shares of 53,640,895.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.